The increasing demand for personalized medicine, numerous advancements in genetic engineering, and the rapid integration of AI in the biopharmaceutical market are some of the major factors propelling growth in the biotech industry.
Given the industry’s bright prospects, it could be wise to buy fundamentally strong biotech stocks, Exelixis, Inc. (EXEL), Vertex Pharmaceuticals Incorporated (VRTX), and Jazz Pharmaceuticals plc (JAZZ), which might offer solid returns.
